biopharmaapac.com Open in urlscan Pro
2a02:4780:84:b272:4010:9111:d490:bc2d Public Scan

Go To Rescan
Add Verdict Report

Submitted URL:
https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6ImRldG91cl9saW5rIiwia...
Effective URL:
https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvq...
Submission: On May 08 via api (May 8th 2024, 1:39:27 am UTC) from DE — Scanned from DE

Summary HTTP 42 Redirects Links 9 Behaviour Indicators

Summary

This website contacted 8 IPs in 4 countries across 8 domains to perform 42 HTTP transactions. The main IP is 2a02:4780:84:b272:4010:9111:d490:bc2d, located in Cyprus and belongs to AS-HOSTINGER, CY. The main domain is biopharmaapac.com.
TLS certificate: Issued by R3 on May 6th 2024. Valid for: 3 months.

This is the only time biopharmaapac.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

	IP Address	AS Autonomous System
1 1	54.236.87.105 54.236.87.105	14618 (AMAZON-AES) (AMAZON-AES)
31	2a02:4780:84:... 2a02:4780:84:b272:4010:9111:d490:bc2d	47583 (AS-HOSTINGER) (AS-HOSTINGER)
1	2a00:1450:400... 2a00:1450:4001:82f::200e	15169 (GOOGLE) (GOOGLE)
5	2a00:1450:400... 2a00:1450:4001:830::2004	15169 (GOOGLE) (GOOGLE)
1	93.184.220.66 93.184.220.66	15133 (EDGECAST) (EDGECAST)
1	2a00:1450:400... 2a00:1450:4001:831::2008	15169 (GOOGLE) (GOOGLE)
1	146.75.120.157 146.75.120.157	54113 (FASTLY) (FASTLY)
1	2a00:1450:400... 2a00:1450:4001:800::2003	15169 (GOOGLE) (GOOGLE)
1	2001:4860:480... 2001:4860:4802:32::36	15169 (GOOGLE) (GOOGLE)
42	8

1 54.236.87.105 (Ashburn, United States) 1 redirects

ASN14618 (AMAZON-AES, US)
PTR: ec2-54-236-87-105.compute-1.amazonaws.com

t.dripemail2.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

31 2a02:4780:84:b272:4010:9111:d490:bc2d (Cyprus)

ASN47583 (AS-HOSTINGER, CY)

biopharmaapac.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:82f::200e (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.youtube.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

5 2a00:1450:4001:830::2004 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.google.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 93.184.220.66 (London, United Kingdom)

ASN15133 (EDGECAST, US)

platform.twitter.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:831::2008 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.googletagmanager.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 146.75.120.157 (Frankfurt am Main, Germany)

ASN54113 (FASTLY, US)

platform.twitter.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:800::2003 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.gstatic.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2001:4860:4802:32::36 (United States)

ASN15169 (GOOGLE, US)

region1.google-analytics.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

	Apex Domain Subdomains	Transfer
31	biopharmaapac.com biopharmaapac.com	867 KB
5	google.com www.google.com — Cisco Umbrella Rank: 2	855 B
2	twitter.com platform.twitter.com — Cisco Umbrella Rank: 1357	28 KB
1	google-analytics.com region1.google-analytics.com — Cisco Umbrella Rank: 2533	255 B
1	gstatic.com www.gstatic.com	203 KB
1	googletagmanager.com www.googletagmanager.com — Cisco Umbrella Rank: 39	99 KB
1	youtube.com www.youtube.com — Cisco Umbrella Rank: 64
1	dripemail2.com 1 redirects t.dripemail2.com — Cisco Umbrella Rank: 191453	240 B
42	8

	Domain	Requested by
31	biopharmaapac.com	biopharmaapac.com
5	www.google.com	biopharmaapac.com www.gstatic.com
2	platform.twitter.com	biopharmaapac.com platform.twitter.com
1	region1.google-analytics.com	www.googletagmanager.com
1	www.gstatic.com	www.google.com
1	www.googletagmanager.com	biopharmaapac.com
1	www.youtube.com	biopharmaapac.com
1	t.dripemail2.com	1 redirects
42	8

This site contains links to these domains. Also see Links.

Domain
eppendorf.group
digitalinsights.qiagen.com
www.sigmaaldrich.com
www.thermofisher.com
tinyurl.com
www.biopharmaapac.com
lifesciences.entegris.com
www.linkedin.com
twitter.com

Subject Issuer	Validity	Valid
biopharmaapac.com R3	`2024-05-06` - `2024-08-04`	3 months	crt.sh
*.google.com GTS CA 1C3	`2024-04-16` - `2024-07-09`	3 months	crt.sh
*.twimg.com DigiCert Global G2 TLS RSA SHA256 2020 CA1	`2023-07-28` - `2024-07-26`	a year	crt.sh
*.google-analytics.com GTS CA 1C3	`2024-04-16` - `2024-07-09`	3 months	crt.sh
*.gstatic.com GTS CA 1C3	`2024-04-16` - `2024-07-09`	3 months	crt.sh

This page contains 7 frames:

Primary Page: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Frame ID: 060659C3F1E6682AB5F02DA68C908A45
Requests: 36 HTTP requests in this frame

Frame: https://www.youtube.com/embed/lOcQEjAN7YU
Frame ID: 1332C25F64D794600E29FAEEE743CEA9
Requests: 1 HTTP requests in this frame

Frame: https://platform.twitter.com/widgets/widget_iframe.2f70fb173b9000da126c79afe2098f02.html?origin=https%3A%2F%2Fbiopharmaapac.com
Frame ID: D1C267FB58F4938AD3713553EA42BD59
Requests: 1 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=de&v=V6_85qpc2Xf2sbe3xTnRte7m&size=normal&cb=ujmv32ykag5s
Frame ID: 616086277479F94B9F812F36BE6EE2C6
Requests: 1 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=de&v=V6_85qpc2Xf2sbe3xTnRte7m&size=normal&cb=rndln7wbabdg
Frame ID: C18B8F95268B1341F01D74FC61DE3755
Requests: 1 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/bframe?hl=de&v=V6_85qpc2Xf2sbe3xTnRte7m&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC
Frame ID: 789E35CD9F7739D34D65A8EF753CBE0A
Requests: 1 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/bframe?hl=de&v=V6_85qpc2Xf2sbe3xTnRte7m&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC
Frame ID: 43C9C1D4298D6F1DBEC48F3EE5DF5956
Requests: 1 HTTP requests in this frame

Screenshot
Live screenshot

Full Image

Page Title

Cytiva Innovates in Gene Therapy with Launch of ELEVECTA Cell Lines

Page URL History Show full URLs

https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6I... HTTP 307
https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-... Page URL

Detected technologies

Bootstrap (Web Frameworks) Expand

Overall confidence: 100%
Detected patterns

<link[^>]* href=[^>]*?bootstrap(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)[^>]*?(?:\.min)?\.css
bootstrap(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)[^>]*?(?:\.min)?\.js

Font Awesome (Font Scripts) Expand

Overall confidence: 100%
Detected patterns

<link[^>]* href=[^>]+(?:([\d.]+)/)?(?:css/)?font-awesome(?:\.min)?\.css
<link[^>]* href=[^>]*?(?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)
(?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:.*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)

Google Analytics (Analytics) Expand

Overall confidence: 100%
Detected patterns

Google Tag Manager (Tag Managers) Expand

Overall confidence: 100%
Detected patterns

googletagmanager\.com/gtag/js

Twitter (Widgets) Expand

Overall confidence: 100%
Detected patterns

//platform\.twitter\.com/widgets\.js

jQuery (JavaScript Libraries) Expand

Overall confidence: 100%
Detected patterns

jquery[.-]([\d.]*\d)[^/]*\.js
jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?

reCAPTCHA (Captchas) Expand

Overall confidence: 100%
Detected patterns

/recaptcha/api\.js

Page Statistics

42
Requests

100 %
HTTPS

67 %
IPv6

8
Domains

8
Subdomains

8
IPs

4
Countries

1197 kB
Transfer

2097 kB
Size

6
Cookies

9 Outgoing links

These are links going to different origins than the main page.

URL: https://eppendorf.group/lpctkq

Search URL Search Domain Scan URL

URL: https://digitalinsights.qiagen.com/biomedical-knowledge-base/

Search URL Search Domain Scan URL

URL: https://www.sigmaaldrich.com/IN/en/campaigns/cancer-research-solutions

Search URL Search Domain Scan URL

URL: https://www.thermofisher.com/sg/en/home/life-science/bioproduction/single-use-bioprocessing/flexible-containment/universal-retention-devices.html?cid=sud_flx_bit_r04_sg_cp1615_pjt11638_col000000_0db_bpc_da_awa_vt_s00_biotitanbpa

Search URL Search Domain Scan URL

URL: http://tinyurl.com/494b3s7w

Search URL Search Domain Scan URL

URL: https://www.biopharmaapac.com/thermofisher-mediabydesign

Search URL Search Domain Scan URL

URL: https://lifesciences.entegris.com/en/home/resources/industry-insights/filter-bag-assembly.html

Search URL Search Domain Scan URL

URL: https://www.linkedin.com/company/biopharmaapac-news

Search URL Search Domain Scan URL

URL: https://twitter.com/BiopharmaApac

Search URL Search Domain Scan URL

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6ImRldG91cl9saW5rIiwiaWF0IjoxNzE1MDg1NTkyLCJuYmYiOjE3MTUwODU1OTIsImFjY291bnRfaWQiOiI2MTU3NjEzIiwiZGVsaXZlcnlfaWQiOiJ1ejd2ZGZxbGJsZ2pzbHA3YjdyaCIsInVybCI6Imh0dHBzOi8vYmlvcGhhcm1hYXBhYy5jb20vbmV3cy8xMzQvNDczOC9jeXRpdmEtaW5ub3ZhdGVzLWluLWdlbmUtdGhlcmFweS13aXRoLWxhdW5jaC1vZi1lbGV2ZWN0YS1jZWxsLWxpbmVzLmh0bWw_X19zPTVzbHZxZmY2d3YybTdtNmUybDlpJnV0bV9zb3VyY2U9ZHJpcCZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9jYW1wYWlnbj1TY2l3aW5kK0Jpb3NjaWVuY2VzK1RlYW1zK1VwK3dpdGgrSEsraW5uby5OK3RvK1RhY2tsZStEaWFiZXRlcytpbitTb3V0aCtLb3JlYSJ9.4JGXjO9autPiyM0tFSc3DNWQdfCIwjpgC6RajIGIEig HTTP 307
https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

42 HTTP transactions
0 data transactions

Method
Protocol Status Resource
Path Size
x-fer Time
Latency Type
MIME-Type IP
Location

GET
H2

200

Primary Request cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html Show response
biopharmaapac.com/news/134/4738/
Redirect Chain

https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6ImRldG91cl9saW5rIiwiaWF0IjoxNzE1MDg1NTkyLCJuYmYiOjE3MTUwODU1OTIsImFjY291bnRfaWQiOiI2MTU3NjEzIiwiZ...
https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosc...

55 KB
16 KB

1332ms
1110ms

Document
text/html

2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

hcdn / PHP/7.0.33

Resource Hash

80f7a4d77863bbe202bb53f37ac2f128b5e2f7c5eaa9477ec17cbafa57fb175a

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

Accept-Language: de-DE,de;q=0.9;q=0.9
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile: ?0
sec-ch-ua-platform: "Win32"

Response headers

alt-svc: h3=":443"; ma=86400
cache-control: no-cache
content-encoding: br
content-security-policy: upgrade-insecure-requests
content-type: text/html; charset=UTF-8
date: Wed, 08 May 2024 01:39:21 GMT
platform: hostinger
server: hcdn
x-hcdn-cache-status: DYNAMIC
x-hcdn-request-id: 724ee4b042f4b170e2b4b95c96bd06b0-bnk-edge2
x-hcdn-upstream-rt: 1.074
x-powered-by: PHP/7.0.33

Redirect headers

content-length: 0
date: Wed, 08 May 2024 01:39:19 GMT
location: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea

GET
H2 200 bootstrap.min.css
biopharmaapac.com/bundles/taai/app/site/css/ 157 KB
21 KB 79ms
77ms Stylesheet
text/css 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/css/bootstrap.min.css

Requested by

Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

hcdn /

Resource Hash

f77c0d1739b618edc4a01ca3f6b2990b01a3009030af49ee8cf68e83052df194

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
age: 503
alt-svc: h3=":443"; ma=86400
content-length: 21008
x-hcdn-cache-status: HIT
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: hcdn
etag: "27288-658841b5-c558fc44806ec9b6;br"
x-hcdn-request-id: 4eb2bd0b547a9964001f600c9ff68eab-bnk-edge2
content-type: text/css
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
expires: Wed, 15 May 2024 01:30:58 GMT

GET
H2 200 style.css
biopharmaapac.com/bundles/taai/app/site/css/ 25 KB
6 KB 78ms
77ms Stylesheet
text/css 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/css/style.css

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

hcdn /

Resource Hash

ebdc5cfff9a360616e819fbd3cb79de32c18c8cc9bf5fde761c69b015ccab1d5

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
age: 503
alt-svc: h3=":443"; ma=86400
content-length: 5242
x-hcdn-cache-status: HIT
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: hcdn
etag: "6585-658841b5-d7545e5fc4eb3b36;br"
x-hcdn-request-id: 2f54faef799175269c8799a2356c6d99-bnk-edge2
content-type: text/css
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
expires: Wed, 15 May 2024 01:30:58 GMT

GET
H2 200 font-awesome.min.css
biopharmaapac.com/bundles/taai/app/site/css/ 20 KB
5 KB 78ms
77ms Stylesheet
text/css 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/css/font-awesome.min.css

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

hcdn /

Resource Hash

b769324e0921f9f649611113e65f528ebae5e140da8a7e63c5d6ea7bc7a33bc0

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
age: 503
alt-svc: h3=":443"; ma=86400
content-length: 4377
x-hcdn-cache-status: HIT
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: hcdn
etag: "511e-658841b5-37cf0363bbbb9110;br"
x-hcdn-request-id: c25bedad70c6078258baa4d0fc3cdc8a-bnk-edge2
content-type: text/css
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
expires: Wed, 15 May 2024 01:30:58 GMT

GET
H2 200 normalize.min.css
biopharmaapac.com/bundles/taai/app/site/css/ 2 KB
1 KB 78ms
78ms Stylesheet
text/css 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/css/normalize.min.css

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

hcdn /

Resource Hash

b76ffbb2665f82b493e054b50d3d1bb3f2a8b4233be1795ca9937956eef196bc

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
age: 503
alt-svc: h3=":443"; ma=86400
content-length: 807
x-hcdn-cache-status: HIT
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: hcdn
etag: "897-658841b5-7766ac21e4fe004a;br"
x-hcdn-request-id: 28be42d1ae2ae3baaef003c9c9c0d3d4-bnk-edge2
content-type: text/css
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
expires: Wed, 15 May 2024 01:30:58 GMT

GET
H2 200 custom-style.css
biopharmaapac.com/bundles/taai/app/site/css/ 342 B
545 B 79ms
78ms Stylesheet
text/css 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/css/custom-style.css

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

hcdn /

Resource Hash

e65117229d77c2ee86fca1f8753df08d81434bf55569e574a03bcabce77ce436

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
age: 503
alt-svc: h3=":443"; ma=86400
content-length: 153
x-hcdn-cache-status: HIT
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: hcdn
etag: "156-658841b5-b5014e6d05cc6cea;br"
x-hcdn-request-id: 6f7e2b26df1aa7165c52cd47f47ff37b-bnk-edge2
content-type: text/css
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
expires: Wed, 15 May 2024 01:30:58 GMT

GET
H2 200 logo.jpg
biopharmaapac.com/bundles/taai/app/site/images/ 5 KB
6 KB 140ms
138ms Image
image/webp 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://biopharmaapac.com/bundles/taai/app/site/images/logo.jpg
Requested by: Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software: hcdn /
Resource Hash: aaa9d19086840932772e9956fdb439edd3f6b0e8f591de53ce6d4dbddf1fa633

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
x-hcdn-cache-status: HIT
server: hcdn
age: 4964
x-hcdn-request-id: efeb237df811fc99a0d205780dfe0055-bnk-edge2
content-type: image/webp
cache-control: public, max-age=604800
x-hcdn-image-optimizer: f:webp q:85 w:1600
accept-ranges: bytes
alt-svc: h3=":443"; ma=86400
content-length: 5400

GET
H2 200 displayad_bioflo320_728x90px_en-58.gif
biopharmaapac.com/uploads/static/ 67 KB
67 KB 111ms
110ms Image
image/gif 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/uploads/static/displayad_bioflo320_728x90px_en-58.gif

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

hcdn /

Resource Hash

727716580a27f67355a553de8a1ee6c1b0b96e3d31e403c26a50a8d0e38fc57a

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
content-security-policy: upgrade-insecure-requests
age: 4964
alt-svc: h3=":443"; ma=86400
content-length: 68096
x-hcdn-cache-status: HIT
last-modified: Tue, 30 Apr 2024 07:41:18 GMT
server: hcdn
etag: "10a00-6630a09e-f7360aa79256a458;;;"
x-hcdn-request-id: 9fd03a65e246a7273e3afd9ed21143ac-bnk-edge2
content-type: image/gif
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
expires: Wed, 15 May 2024 00:16:37 GMT

GET
H2 200 17247404334195733326-59.jpg
biopharmaapac.com/uploads/static/ 15 KB
15 KB 139ms
138ms Image
image/webp 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://biopharmaapac.com/uploads/static/17247404334195733326-59.jpg
Requested by: Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software: hcdn /
Resource Hash: f91416ebe951deb0a4fc0a0fcf1be8a096cfa51f77ef083129a80a89a56016c1

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
x-hcdn-cache-status: HIT
server: hcdn
age: 4964
x-hcdn-request-id: 2ebdfcaf7f5a45c8f8dabe01e897280d-bnk-edge2
content-type: image/webp
cache-control: public, max-age=604800
x-hcdn-image-optimizer: f:webp q:85 w:1600
accept-ranges: bytes
alt-svc: h3=":443"; ma=86400
content-length: 15330

GET
H2 200 1715064986063-4738.jpg
biopharmaapac.com/uploads/articles/ 29 KB
29 KB 139ms
138ms Image
image/webp 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://biopharmaapac.com/uploads/articles/1715064986063-4738.jpg
Requested by: Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software: hcdn /
Resource Hash: e532f1b2141f3cbdcfec9301d40fd59b1babd686985746e07014c9bfc68bcf1a

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
x-hcdn-cache-status: HIT
server: hcdn
age: 4776
x-hcdn-request-id: 34048f39420aa1516fc912a33a115ace-bnk-edge2
content-type: image/webp
cache-control: public, max-age=604800
x-hcdn-image-optimizer: f:webp q:85 w:1600
accept-ranges: bytes
alt-svc: h3=":443"; ma=86400
content-length: 29254

GET
H2 200 16421605736357482910-2105.png
biopharmaapac.com/uploads/static/ 24 KB
24 KB 139ms
139ms Image
image/webp 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://biopharmaapac.com/uploads/static/16421605736357482910-2105.png
Requested by: Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software: hcdn /
Resource Hash: a94ec9082fdaf7a1274e6159c1aada2f7dad7adf2bbddd7033812740af162153

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
x-hcdn-cache-status: HIT
server: hcdn
age: 4964
x-hcdn-request-id: 587644bd04f33e3f2573b105717fdcaa-bnk-edge2
content-type: image/webp
cache-control: public, max-age=604800
x-hcdn-image-optimizer: f:webp q:85 w:1600
accept-ranges: bytes
alt-svc: h3=":443"; ma=86400
content-length: 24572

GET
H2 200 biotitan_banner_300x250_v_2-61.jpg
biopharmaapac.com/uploads/static/ 11 KB
11 KB 210ms
209ms Image
image/webp 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://biopharmaapac.com/uploads/static/biotitan_banner_300x250_v_2-61.jpg
Requested by: Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software: hcdn /
Resource Hash: d7d904e9a98515edf42a248c8cc167fb564c5b9ef545b362027ea4225a9eeb45

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
x-hcdn-cache-status: HIT
server: hcdn
age: 4964
x-hcdn-request-id: db40539c4ef5498a0ca35805dd31ca41-bnk-edge2
content-type: image/webp
cache-control: public, max-age=604800
x-hcdn-image-optimizer: f:webp q:85 w:1600
accept-ranges: bytes
alt-svc: h3=":443"; ma=86400
content-length: 11444

GET
H2 200 biopharma_apac_website_banner_300_x_150_px_2_-64.png
biopharmaapac.com/uploads/static/ 11 KB
11 KB 210ms
210ms Image
image/webp 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://biopharmaapac.com/uploads/static/biopharma_apac_website_banner_300_x_150_px_2_-64.png
Requested by: Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software: hcdn /
Resource Hash: 2ea8b83f155a1c7a1b24ef264a3cdc3e0ccf8627d447962adc7168225855b10c

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
x-hcdn-cache-status: HIT
server: hcdn
age: 4964
x-hcdn-request-id: 420d60a7eead1a5645274f9f0eaf5e65-bnk-edge2
content-type: image/webp
cache-control: public, max-age=604800
x-hcdn-image-optimizer: f:webp q:85 w:1600
accept-ranges: bytes
alt-svc: h3=":443"; ma=86400
content-length: 11080

GET
H2 200 unnamed-62.gif
biopharmaapac.com/uploads/static/ 36 KB
37 KB 210ms
210ms Image
image/gif 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/uploads/static/unnamed-62.gif

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

hcdn /

Resource Hash

461c3cb2d353f837be8a4d1b9ed67e8accdce9af1d69fb0819e9c3d593fb06e0

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
content-security-policy: upgrade-insecure-requests
age: 4964
alt-svc: h3=":443"; ma=86400
content-length: 37253
x-hcdn-cache-status: HIT
last-modified: Thu, 15 Feb 2024 04:36:58 GMT
server: hcdn
etag: "9185-65cd94ea-254f3b0d30889995;;;"
x-hcdn-request-id: 058c8a9774d31a0660ee46adfb054923-bnk-edge2
content-type: image/gif
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
expires: Wed, 15 May 2024 00:16:37 GMT

GET
H2 200 lOcQEjAN7YU
www.youtube.com/embed/ Frame 1332 0
0 110ms
70ms Document
text/html 2a00:1450:4001:82f::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.youtube.com/embed/lOcQEjAN7YU

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:82f::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

ESF /

Resource Hash

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Accept-Language: de-DE,de;q=0.9;q=0.9
Referer: https://biopharmaapac.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile: ?0
sec-ch-ua-platform: "Win32"

Response headers

accept-ch: Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control: no-cache, no-store, max-age=0, must-revalidate
content-encoding: br
content-type: text/html; charset=utf-8
cross-origin-opener-policy-report-only: same-origin; report-to="youtube_main"
cross-origin-resource-policy: cross-origin
date: Wed, 08 May 2024 01:39:21 GMT
expires: Mon, 01 Jan 1990 00:00:00 GMT
origin-trial: AmhMBR6zCLzDDxpW+HfpP67BqwIknWnyMOXOQGfzYswFmJe+fgaI6XZgAzcxOrzNtP7hEDsOo1jdjFnVr2IdxQ4AAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTc1ODA2NzE5OSwiaXNTdWJkb21haW4iOnRydWV9
p3p: CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
permissions-policy: ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
pragma: no-cache
report-to: {"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
server: ESF
strict-transport-security: max-age=31536000
vary: Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
x-content-type-options: nosniff
x-xss-protection: 0

GET
H2 200 14280220722498395040-63.jpg
biopharmaapac.com/uploads/static/ 10 KB
11 KB 173ms
168ms Image
image/webp 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://biopharmaapac.com/uploads/static/14280220722498395040-63.jpg
Requested by: Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software: hcdn /
Resource Hash: 59be31622cb5372db4b737dfa5f7ff640ef4112b160f1b9d87609633d8ea1514

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
x-hcdn-cache-status: HIT
server: hcdn
age: 4964
x-hcdn-request-id: 7c3067a55bc709e749933b73deefaea8-bnk-edge2
content-type: image/webp
cache-control: public, max-age=604800
x-hcdn-image-optimizer: f:webp q:85 w:1600
accept-ranges: bytes
alt-svc: h3=":443"; ma=86400
content-length: 10606

GET
H2 200 biopharma_apac_women_s_day_special-4471.jpg
biopharmaapac.com/uploads/articles/ 170 KB
171 KB 173ms
168ms Image
image/webp 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://biopharmaapac.com/uploads/articles/biopharma_apac_women_s_day_special-4471.jpg
Requested by: Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software: hcdn /
Resource Hash: 3248ad72ca2f25d3874e6a6dca3ecb489d6484a060287603c7d5e840d8e584c6

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
x-hcdn-cache-status: HIT
server: hcdn
age: 4963
x-hcdn-request-id: 61a8ec48f0e288d23e243f895984cc72-bnk-edge2
content-type: image/webp
cache-control: public, max-age=604800
x-hcdn-image-optimizer: f:webp q:85 w:1600
accept-ranges: bytes
alt-svc: h3=":443"; ma=86400
content-length: 174190

GET
H2 200 screenshot_2023_12_13_at_9_44_52_am_1_-4048.jpg
biopharmaapac.com/uploads/articles/ 53 KB
54 KB 173ms
168ms Image
image/webp 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://biopharmaapac.com/uploads/articles/screenshot_2023_12_13_at_9_44_52_am_1_-4048.jpg
Requested by: Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software: hcdn /
Resource Hash: 05a10bd44e20f26c785b3e4c31295801b9705145585465938c424d9af7bd66af

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
x-hcdn-cache-status: HIT
server: hcdn
age: 4963
x-hcdn-request-id: f2c1e62c7d41acb2fa7ab7be6612c5d6-bnk-edge2
content-type: image/webp
cache-control: public, max-age=604800
x-hcdn-image-optimizer: f:webp q:85 w:1600
accept-ranges: bytes
alt-svc: h3=":443"; ma=86400
content-length: 54622

GET
H2 200 screenshot_2023_12_12_at_9_45_03_pm-4050.jpg
biopharmaapac.com/uploads/articles/ 69 KB
70 KB 175ms
171ms Image
image/webp 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://biopharmaapac.com/uploads/articles/screenshot_2023_12_12_at_9_45_03_pm-4050.jpg
Requested by: Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software: hcdn /
Resource Hash: fb58550a82dc1147bd4dd6896f9b37a844ad655377c361757eb9f64c9e732235

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
x-hcdn-cache-status: HIT
server: hcdn
age: 4963
x-hcdn-request-id: d9bf5741d939254349c523ad05f284d1-bnk-edge2
content-type: image/webp
cache-control: public, max-age=604800
x-hcdn-image-optimizer: f:webp q:85 w:1600
accept-ranges: bytes
alt-svc: h3=":443"; ma=86400
content-length: 70900

GET
H2 200 BPA-Newsletter.jpg
biopharmaapac.com/bundles/taai/app/site/images/ 16 KB
17 KB 175ms
171ms Image
image/webp 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://biopharmaapac.com/bundles/taai/app/site/images/BPA-Newsletter.jpg
Requested by: Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software: hcdn /
Resource Hash: 179c2e3f2a72fdfd5273c72316683096c013116f3c94140e1bd9e8571326d039

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
x-hcdn-cache-status: HIT
server: hcdn
age: 4963
x-hcdn-request-id: f6ea238250402ca3aaede7710b799bdf-bnk-edge2
content-type: image/webp
cache-control: public, max-age=604800
x-hcdn-image-optimizer: f:webp q:85 w:1600
accept-ranges: bytes
alt-svc: h3=":443"; ma=86400
content-length: 16642

GET
H2 200 jquery-3.6.0.min.js Show response
biopharmaapac.com/bundles/taai/app/site/js/ 87 KB
30 KB 172ms
169ms Script
application/x-javascript 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/js/jquery-3.6.0.min.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

hcdn /

Resource Hash

ff1523fb7389539c84c65aba19260648793bb4f5e29329d2ee8804bc37a3fe6e

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
age: 4964
alt-svc: h3=":443"; ma=86400
content-length: 30021
x-hcdn-cache-status: HIT
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: hcdn
etag: "15d9d-658841b5-76abcfcbc9734b31;br"
x-hcdn-request-id: bcf480958643d414fa01eb50dc2472d4-bnk-edge2
content-type: application/x-javascript
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
expires: Wed, 15 May 2024 00:16:37 GMT

GET
H2 200 popper.min.js Show response
biopharmaapac.com/bundles/taai/app/site/js/ 21 KB
7 KB 172ms
169ms Script
application/x-javascript 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/js/popper.min.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

hcdn /

Resource Hash

c776195ad46333c6c9a9fe3c74502ffea9a02faf122388ea3567922cc65a3060

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
age: 4964
alt-svc: h3=":443"; ma=86400
content-length: 7193
x-hcdn-cache-status: HIT
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: hcdn
etag: "5309-658841b5-f0a1cf827833c88e;br"
x-hcdn-request-id: 6f797b58cfc5f274cf1029153433ff9b-bnk-edge2
content-type: application/x-javascript
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
expires: Wed, 15 May 2024 00:16:37 GMT

GET
H2 200 bootstrap.min.js Show response
biopharmaapac.com/bundles/taai/app/site/js/ 62 KB
14 KB 172ms
169ms Script
application/x-javascript 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/js/bootstrap.min.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

hcdn /

Resource Hash

d8968086f7509df34c3278563dab87399da4f9dcdfb419818e3a309eedc70b88

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
age: 4964
alt-svc: h3=":443"; ma=86400
content-length: 14080
x-hcdn-cache-status: HIT
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: hcdn
etag: "f708-658841b5-af11bc98bc815e7d;br"
x-hcdn-request-id: 6eec0028f9fcf9b503d93a65d741d7cb-bnk-edge2
content-type: application/x-javascript
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
expires: Wed, 15 May 2024 00:16:37 GMT

GET
H2 200 jquery.autoscroll.js Show response
biopharmaapac.com/bundles/taai/app/site/js/ 1 KB
969 B 172ms
170ms Script
application/x-javascript 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/js/jquery.autoscroll.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

hcdn /

Resource Hash

c6be6411d784cb509362d794eb35273a24661f430ef0858982cac95fbb23e23d

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
age: 4964
alt-svc: h3=":443"; ma=86400
content-length: 565
x-hcdn-cache-status: HIT
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: hcdn
etag: "59b-658841b5-93f15deffd8af24b;br"
x-hcdn-request-id: ded95f6f57eb910fd7e5203615269caf-bnk-edge2
content-type: application/x-javascript
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
expires: Wed, 15 May 2024 00:16:37 GMT

GET
H2 200 script.js Show response
biopharmaapac.com/bundles/taai/app/site/js/ 8 KB
2 KB 172ms
170ms Script
application/x-javascript 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/js/script.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

hcdn /

Resource Hash

6ac1a1a6d852a4b597abee6351f122b5363f1c3f153df5a2b60336bbbe61069d

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
age: 4964
alt-svc: h3=":443"; ma=86400
content-length: 1868
x-hcdn-cache-status: HIT
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: hcdn
etag: "1ed5-658841b5-3be2fb36bd88fc41;br"
x-hcdn-request-id: 312b802aa3a341d404f14899a9b6022a-bnk-edge2
content-type: application/x-javascript
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
expires: Wed, 15 May 2024 00:16:37 GMT

GET
H2 200 dips-site-common.js Show response
biopharmaapac.com/bundles/taai/app/site/js/ 5 KB
2 KB 173ms
170ms Script
application/x-javascript 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/js/dips-site-common.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

hcdn /

Resource Hash

b316099d3d0439715256c4bf9b8b59f2323a0af63e65b33e668a1eb3972f2893

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
age: 4964
alt-svc: h3=":443"; ma=86400
content-length: 1639
x-hcdn-cache-status: HIT
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: hcdn
etag: "13f4-658841b5-e31a95c6373499c0;br"
x-hcdn-request-id: c6c658f01dcb0991fca512b915c1f521-bnk-edge2
content-type: application/x-javascript
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
expires: Wed, 15 May 2024 00:16:37 GMT

GET
H3 200 api.js Show response
www.google.com/recaptcha/ 1 KB
855 B 38ms
19ms Script
text/javascript 2a00:1450:4001:830::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api.js

Requested by

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:830::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

b4a87969c4cc52d70e75db24b6bda485dbb1beef9ab5c4074e4020176ea1713b

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
content-encoding: gzip
x-content-type-options: nosniff
content-security-policy: frame-ancestors 'self'
server: GSE
x-frame-options: SAMEORIGIN
content-type: text/javascript; charset=utf-8
cache-control: private, max-age=300
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection: 1; mode=block
expires: Wed, 08 May 2024 01:39:21 GMT

GET
H/1.1 200
OK widgets.js Show response
platform.twitter.com/ 91 KB
28 KB 42ms
7ms Script
application/javascript 93.184.220.66
EDGECAST

General

Check archive.org

Show headers Download Go to

Full URL: https://platform.twitter.com/widgets.js
Requested by: Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_256_GCM
Server: 93.184.220.66 London, United Kingdom, ASN15133 (EDGECAST, US),
Reverse DNS
Software: ECS (frb/668B) /
Resource Hash: 173460e89e6a7244218badae2016f65c48a3eae9d400802273eeca18b07336f1

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Date: Wed, 08 May 2024 01:39:21 GMT
Content-Encoding: gzip
Age: 389
x-amz-server-side-encryption: AES256
X-Cache: HIT
P3P: CP="CAO DSP LAW CURa ADMa DEVa TAIa PSAa PSDa IVAa IVDa OUR BUS IND UNI COM NAV INT"
Server-Timing: x-cache;desc= HIT,x-tw-cdn;desc=VZ
Content-Length: 27597
Last-Modified: Mon, 11 Dec 2023 17:20:28 GMT
Server: ECS (frb/668B)
Etag: "824beb891744db98ccbd3a456e59e0f7+gzip"
Access-Control-Max-Age: 3000
Access-Control-Allow-Methods: GET
Content-Type: application/javascript; charset=utf-8
Access-Control-Allow-Origin: *
x-tw-cdn: VZ
Cache-Control: public, max-age=1800
Vary: Accept-Encoding

GET
H2 200 articulate.min.js Show response
biopharmaapac.com/bundles/taai/assets/global/plugins/text-to-speech/ 8 KB
3 KB 137ms
134ms Script
application/x-javascript 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/assets/global/plugins/text-to-speech/articulate.min.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

hcdn /

Resource Hash

a8a2031f7cb98a60f55670a991ce71d4b61aaf051a4bf4eaccb2620b218516ec

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
age: 4964
alt-svc: h3=":443"; ma=86400
content-length: 2410
x-hcdn-cache-status: HIT
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: hcdn
etag: "1e7c-658841b5-526d778e2c41316a;br"
x-hcdn-request-id: 6743d35eeaaf0a144e6f4107a59652a5-bnk-edge2
content-type: application/x-javascript
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
expires: Wed, 15 May 2024 00:16:37 GMT

GET
H2 200 js Show response
www.googletagmanager.com/gtag/ 290 KB
99 KB 49ms
26ms Script
application/javascript 2a00:1450:4001:831::2008
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtag/js?id=G-2E2BXNMKP4

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:831::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

f72683fd4c72ab8ba3a22f51c7a9cd39fe0feefb4c77d04e98891067659934eb

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
content-encoding: br
strict-transport-security: max-age=31536000; includeSubDomains
server: Google Tag Manager
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: private, max-age=900
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
access-control-allow-headers: Cache-Control
content-length: 100884
x-xss-protection: 0
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires: Wed, 08 May 2024 01:39:21 GMT

GET
H3 200 back-web.jpg
biopharmaapac.com/bundles/taai/app/site/images/ 132 KB
133 KB 34ms
34ms Image
image/webp 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://biopharmaapac.com/bundles/taai/app/site/images/back-web.jpg
Requested by: Host: biopharmaapac.com
URL: https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Protocol: H3
Security: QUIC, , AES_128_GCM
Server: 2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software: hcdn /
Resource Hash: 9807538ba07b58d5a1eeec2c0f131ded66114b057b3f64e56d5e2e9fd7d0ca7a

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
x-hcdn-cache-status: HIT
server: hcdn
age: 501
x-hcdn-request-id: b18226ac55ec0226aae87664919c091f-bnk-edge2
content-type: image/webp
cache-control: public, max-age=604800
x-hcdn-image-optimizer: f:webp q:85 w:1600
accept-ranges: bytes
alt-svc: h3=":443"; ma=86400
content-length: 135608

GET
H3 200 newsletter-back-Banner.jpg
biopharmaapac.com/bundles/taai/app/site/images/ 22 KB
22 KB 36ms
35ms Image
image/webp 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://biopharmaapac.com/bundles/taai/app/site/images/newsletter-back-Banner.jpg
Requested by: Host: biopharmaapac.com
URL: https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Protocol: H3
Security: QUIC, , AES_128_GCM
Server: 2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software: hcdn /
Resource Hash: add1f3a5245e9a1759b07f6311207675be04b3273de0a142403d44370b3f1876

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
x-hcdn-cache-status: HIT
server: hcdn
age: 501
x-hcdn-request-id: 5cfb40d77b08769e4f6641fc7e1cea54-bnk-edge2
content-type: image/webp
cache-control: public, max-age=604800
x-hcdn-image-optimizer: f:webp q:85 w:1600
accept-ranges: bytes
alt-svc: h3=":443"; ma=86400
content-length: 22080

GET
H3 200 cd-icon-close.svg
biopharmaapac.com/bundles/taai/app/site/images/ 696 B
735 B 37ms
37ms Image
image/svg+xml 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/bundles/taai/app/site/images/cd-icon-close.svg

Requested by

Host: biopharmaapac.com
URL: https://biopharmaapac.com/bundles/taai/app/site/css/style.css

Protocol

Security

QUIC, , AES_128_GCM

Server

2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

hcdn /

Resource Hash

ba3c42c97d16d249855dcfeed7daf64b7a6f56bb45948a5b6409c39bf037da92

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
age: 502
alt-svc: h3=":443"; ma=86400
content-length: 351
x-hcdn-cache-status: HIT
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: hcdn
etag: "2b8-658841b5-4ebfd1f75862087e;br"
x-hcdn-request-id: 3bfbf58ddb69caabbad6ec6466fd47de-bnk-edge2
content-type: image/svg+xml
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
expires: Wed, 15 May 2024 01:30:59 GMT

GET
H3 200 fontawesome-webfont.woff
biopharmaapac.com/bundles/taai/app/site/fonts/ 82 KB
82 KB 37ms
37ms Font
application/font-woff 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/fonts/fontawesome-webfont.woff?v=4.1.0

Requested by

Host: biopharmaapac.com
URL: https://biopharmaapac.com/bundles/taai/app/site/css/font-awesome.min.css

Protocol

Security

QUIC, , AES_128_GCM

Server

2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

hcdn /

Resource Hash

66db52b456efe7e29cec11fa09421d03cb09e37ed1b567307ec0444fd605ce31

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/bundles/taai/app/site/css/font-awesome.min.css
Origin: https://biopharmaapac.com
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:21 GMT
content-security-policy: upgrade-insecure-requests
x-hcdn-cache-status: HIT
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: hcdn
age: 502
etag: W/"14730-658841b5-d326144e0621bbb4;;;"
vary: accept-encoding
x-hcdn-request-id: 149d9c63aaea9331b097bae5fa30f7f3-bnk-edge2
content-type: application/font-woff
content-encoding: br
x-turbo-charged-by: LiteSpeed
platform: hostinger
alt-svc: h3=":443"; ma=86400

GET
H2 200 widget_iframe.2f70fb173b9000da126c79afe2098f02.html
platform.twitter.com/widgets/ Frame D1C2 0
0 24ms
6ms Document
text/html 146.75.120.157
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://platform.twitter.com/widgets/widget_iframe.2f70fb173b9000da126c79afe2098f02.html?origin=https%3A%2F%2Fbiopharmaapac.com
Requested by: Host: platform.twitter.com
URL: https://platform.twitter.com/widgets.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 146.75.120.157 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software: /
Resource Hash

Request headers

Accept-Language: de-DE,de;q=0.9;q=0.9
Referer: https://biopharmaapac.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile: ?0
sec-ch-ua-platform: "Win32"

Response headers

accept-ranges: bytes
access-control-allow-methods: GET
access-control-allow-origin: *
cache-control: public, max-age=315360000
content-encoding: gzip
content-length: 105429
content-type: text/html; charset=utf-8
date: Wed, 08 May 2024 01:39:22 GMT
etag: "81267302efdfb3e4524a22631a8fc99e+gzip"
last-modified: Mon, 11 Dec 2023 17:19:49 GMT
p3p: CP="CAO DSP LAW CURa ADMa DEVa TAIa PSAa PSDa IVAa IVDa OUR BUS IND UNI COM NAV INT"
tw-cdn: FT
vary: Accept-Encoding
x-amz-server-side-encryption: AES256
x-cache: HIT, HIT
x-served-by: cache-iad-kjyo7100176-IAD, cache-fra-etou8220071-FRA

GET
H2 200 recaptcha__de.js Show response
www.gstatic.com/recaptcha/releases/V6_85qpc2Xf2sbe3xTnRte7m/ 509 KB
203 KB 565ms
14ms Script
text/javascript 2a00:1450:4001:800::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/V6_85qpc2Xf2sbe3xTnRte7m/recaptcha__de.js

Requested by

Host: www.google.com
URL: https://www.google.com/recaptcha/api.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:800::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

352a6d9b12a5ae3949d370ff42a338ba8bb6ff455d9ba995b1755fb7b99e8824

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/
Origin: https://biopharmaapac.com
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 07 May 2024 14:53:46 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 38736
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 207268
x-xss-protection: 0
last-modified: Mon, 22 Apr 2024 21:03:35 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/javascript
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Wed, 07 May 2025 14:53:46 GMT

POST
H2 204 collect
region1.google-analytics.com/g/ 0
255 B 531ms
13ms Ping
text/plain 2001:4860:4802:32::36
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL: https://region1.google-analytics.com/g/collect?v=2&tid=G-2E2BXNMKP4&gtm=45je4510v877295126za200&_p=1715132361779&gcd=13l3l3l2l1&npa=1&dma_cps=sypham&dma=1&cid=95278643.1715132362&ul=de-de&sr=1600x1200&uaa=x86&uab=64&uafvl=Chromium%3B124.0.6367.118%7CGoogle%2520Chrome%3B124.0.6367.118%7CNot-A.Brand%3B99.0.0.0&uamb=0&uam=&uap=Win32&uapv=10.0.0&uaw=0&frm=0&pscdl=noapi&_s=1&sid=1715132361&sct=1&seg=0&dl=https%3A%2F%2Fbiopharmaapac.com%2Fnews%2F134%2F4738%2Fcytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html%3F__s%3D5slvqff6wv2m7m6e2l9i%26utm_source%3Ddrip%26utm_medium%3Demail%26utm_campaign%3DSciwind%2BBiosciences%2BTeams%2BUp%2Bwith%2BHK%2Binno.N%2Bto%2BTackle%2BDiabetes%2Bin%2BSouth%2BKorea&dt=Cytiva%20Innovates%20in%20Gene%20Therapy%20with%20Launch%20of%20ELEVECTA%20Cell%20Lines&en=page_view&_fv=1&_nsi=1&_ss=1&_ee=1&tfd=2270
Requested by: Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-2E2BXNMKP4
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2001:4860:4802:32::36 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software: Golfe2 /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

pragma: no-cache
date: Wed, 08 May 2024 01:39:22 GMT
server: Golfe2
content-type: text/plain
access-control-allow-origin: https://biopharmaapac.com
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H3 200 anchor
www.google.com/recaptcha/api2/ Frame 6160 0
0 32ms
31ms Document
text/html 2a00:1450:4001:830::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=de&v=V6_85qpc2Xf2sbe3xTnRte7m&size=normal&cb=ujmv32ykag5s

Requested by

Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/V6_85qpc2Xf2sbe3xTnRte7m/recaptcha__de.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:830::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

Security Headers

Name	Value
Content-Security-Policy	script-src 'report-sample' 'nonce-6DwO6FB4-wUekycIc9Jb6w' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Accept-Language: de-DE,de;q=0.9;q=0.9
Referer: https://biopharmaapac.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile: ?0
sec-ch-ua-platform: "Win32"

Response headers

alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control: no-cache, no-store, max-age=0, must-revalidate
content-encoding: gzip
content-security-policy: script-src 'report-sample' 'nonce-6DwO6FB4-wUekycIc9Jb6w' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type: text/html; charset=utf-8
cross-origin-embedder-policy: require-corp
cross-origin-resource-policy: cross-origin
date: Wed, 08 May 2024 01:39:22 GMT
expires: Mon, 01 Jan 1990 00:00:00 GMT
pragma: no-cache
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server: GSE
x-content-type-options: nosniff
x-xss-protection: 1; mode=block

GET
H3 200 anchor
www.google.com/recaptcha/api2/ Frame C18B 0
0 39ms
35ms Document
text/html 2a00:1450:4001:830::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=de&v=V6_85qpc2Xf2sbe3xTnRte7m&size=normal&cb=rndln7wbabdg

Requested by

Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/V6_85qpc2Xf2sbe3xTnRte7m/recaptcha__de.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:830::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

Security Headers

Name	Value
Content-Security-Policy	script-src 'report-sample' 'nonce-8634i5jsEavj6e9KIgewtQ' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Accept-Language: de-DE,de;q=0.9;q=0.9
Referer: https://biopharmaapac.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile: ?0
sec-ch-ua-platform: "Win32"

Response headers

alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control: no-cache, no-store, max-age=0, must-revalidate
content-encoding: gzip
content-security-policy: script-src 'report-sample' 'nonce-8634i5jsEavj6e9KIgewtQ' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type: text/html; charset=utf-8
cross-origin-embedder-policy: require-corp
cross-origin-resource-policy: cross-origin
date: Wed, 08 May 2024 01:39:22 GMT
expires: Mon, 01 Jan 1990 00:00:00 GMT
pragma: no-cache
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server: GSE
x-content-type-options: nosniff
x-xss-protection: 1; mode=block

GET
H3 200 favicon.ico
biopharmaapac.com/ 1 KB
939 B 582ms
581ms Other
image/x-icon 2a02:4780:84:b272:4010:9111:d490:bc2d
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/favicon.ico

Protocol

Security

QUIC, , AES_128_GCM

Server

2a02:4780:84:b272:4010:9111:d490:bc2d , Cyprus, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

hcdn /

Resource Hash

7428eb0737028b660f7ed162a0e6a8971d9fab47a1954ffd07ab90dce5582bad

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 08 May 2024 01:39:23 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
alt-svc: h3=":443"; ma=86400
content-length: 544
x-hcdn-cache-status: MISS
last-modified: Sun, 31 Dec 2023 17:58:04 GMT
server: hcdn
etag: "47e-6591abac-69c23afe33127d87;br"
x-hcdn-request-id: 3fb1a0a9800ca929e29ce2da0649ef1c-bnk-edge2
content-type: image/x-icon
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
x-hcdn-upstream-rt: 0.533
accept-ranges: bytes
platform: hostinger
expires: Wed, 15 May 2024 01:39:23 GMT

GET
H3 200 bframe
www.google.com/recaptcha/api2/ Frame 789E 0
0 19ms
19ms Document
text/html 2a00:1450:4001:830::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api2/bframe?hl=de&v=V6_85qpc2Xf2sbe3xTnRte7m&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC

Requested by

Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/V6_85qpc2Xf2sbe3xTnRte7m/recaptcha__de.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:830::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

Security Headers

Name	Value
Content-Security-Policy	script-src 'report-sample' 'nonce-UAx_rMuAH0Zrox8yvKsjsQ' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Accept-Language: de-DE,de;q=0.9;q=0.9
Referer: https://biopharmaapac.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile: ?0
sec-ch-ua-platform: "Win32"

Response headers

alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control: no-cache, no-store, max-age=0, must-revalidate
content-encoding: gzip
content-security-policy: script-src 'report-sample' 'nonce-UAx_rMuAH0Zrox8yvKsjsQ' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type: text/html; charset=utf-8
cross-origin-embedder-policy: require-corp
cross-origin-resource-policy: cross-origin
date: Wed, 08 May 2024 01:39:22 GMT
expires: Mon, 01 Jan 1990 00:00:00 GMT
pragma: no-cache
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server: GSE
x-content-type-options: nosniff
x-xss-protection: 1; mode=block

GET
H3 200 bframe
www.google.com/recaptcha/api2/ Frame 43C9 0
0 24ms
20ms Document
text/html 2a00:1450:4001:830::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api2/bframe?hl=de&v=V6_85qpc2Xf2sbe3xTnRte7m&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC

Requested by

Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/V6_85qpc2Xf2sbe3xTnRte7m/recaptcha__de.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:830::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

Security Headers

Name	Value
Content-Security-Policy	script-src 'report-sample' 'nonce-OsSMDJsBHz2fMHoBb2vqKw' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Accept-Language: de-DE,de;q=0.9;q=0.9
Referer: https://biopharmaapac.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile: ?0
sec-ch-ua-platform: "Win32"

Response headers

alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control: no-cache, no-store, max-age=0, must-revalidate
content-encoding: gzip
content-security-policy: script-src 'report-sample' 'nonce-OsSMDJsBHz2fMHoBb2vqKw' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type: text/html; charset=utf-8
cross-origin-embedder-policy: require-corp
cross-origin-resource-policy: cross-origin
date: Wed, 08 May 2024 01:39:22 GMT
expires: Mon, 01 Jan 1990 00:00:00 GMT
pragma: no-cache
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server: GSE
x-content-type-options: nosniff
x-xss-protection: 1; mode=block

Verdicts & Comments Add Verdict or Comment

41 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

6 Cookies

Cookies are little pieces of information stored in the browser of a user. Whenever a user visits the site again, he will also send his cookie values, thus allowing the website to re-identify him even if he changed locations. This is how permanent logins work.

Domain/Path	Expires	Name / Value
biopharmaapac.com/	1969-12-31 23:59:59	Name: PHPSESSID Value: ouhdrc08vqbodcii9r06s71mr7
.youtube.com/	1969-12-31 23:59:59	Name: YSC Value: Q70FBwyBUUo
.youtube.com/	1970-01-21 00:44:44	Name: VISITOR_INFO1_LIVE Value: SJZtKMC8mBM
.youtube.com/	1970-01-21 00:44:44	Name: VISITOR_PRIVACY_METADATA Value: CgJERRIEEgAgVw%3D%3D
.biopharmaapac.com/	1970-01-21 06:01:32	Name: _ga_2E2BXNMKP4 Value: GS1.1.1715132361.1.0.1715132361.0.0.0
.biopharmaapac.com/	1970-01-21 06:01:32	Name: _ga Value: GA1.1.95278643.1715132362

1 Console Messages

A page may trigger messages to the console to be logged. These are often error messages about being unable to load a resource or execute a piece of JavaScript. Sometimes they also provide insight into the technology behind a website.

Source	Level	URL Text
recommendation	verbose	URL: https://biopharmaapac.com/news/134/4738/cytiva-innovates-in-gene-therapy-with-launch-of-elevecta-cell-lines.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea Message: [DOM] Input elements should have autocomplete attributes (suggested: "current-password"): (More info: https://goo.gl/9p2vKq) %o

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header	Value
Content-Security-Policy	upgrade-insecure-requests

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

biopharmaapac.com
platform.twitter.com
region1.google-analytics.com
t.dripemail2.com
www.google.com
www.googletagmanager.com
www.gstatic.com
www.youtube.com
146.75.120.157
2001:4860:4802:32::36
2a00:1450:4001:800::2003
2a00:1450:4001:82f::200e
2a00:1450:4001:830::2004
2a00:1450:4001:831::2008
2a02:4780:84:b272:4010:9111:d490:bc2d
54.236.87.105
93.184.220.66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biopharmaapac.com Open in urlscan Pro 2a02:4780:84:b272:4010:9111:d490:bc2d Public Scan

Summary

urlscan.io Verdict: No classification

Domain & IP information

Screenshot Live screenshot Full Image

Page Title

Page URL History Show full URLs

Detected technologies

Page Statistics

42 Requests

100 %HTTPS

67 %IPv6

8 Domains

8 Subdomains

8 IPs

4 Countries

1197 kBTransfer

2097 kBSize

6 Cookies

9 Outgoing links

Page URL History

Redirected requests

42 HTTP transactions Everything HTML Script AJAX CSS Image Expand all 0 data transactions

Request headers

Response headers

Redirect headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

biopharmaapac.com Open in urlscan Pro
2a02:4780:84:b272:4010:9111:d490:bc2d Public Scan

Screenshot
Live screenshot

Full Image

42
Requests

100 %
HTTPS

67 %
IPv6

8
Domains

8
Subdomains

8
IPs

4
Countries

1197 kB
Transfer

2097 kB
Size

6
Cookies

42 HTTP transactions
0 data transactions